GlassScriptPhysician profile
Sostanie Enoru
NPI 1740671254
$2,186.67
in general payments reported to CMS, 2019-2025
15 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $342 · 2021: $471 · 2022: $180 · 2023: $161 · 2024: $244 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $566.63 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $382.86 | 2020-2025 | General - Balloon Catheters, Rotapro, Avvigo Guidance System |
| Abbott Laboratories | $252.20 | 2019-2021 | |
| Biotronik INC. | $213.57 | 2019-2021 | |
| Amgen INC. | $181.77 | 2021-2024 | Repatha |
| Medtronic, INC. | $136.93 | 2021-2025 | Linq II |
| Astrazeneca Pharmaceuticals LP | $129.70 | 2019-2021 | |
| Inari Medical, INC. | $124.86 | 2022 | |
| Shockwave Medical, INC | $57.28 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $26.90 | 2019-2021 | |
| Gilead Sciences, INC. | $25.00 | 2019 | |
| Alnylam Pharmaceuticals INC. | $24.95 | 2020 | |
| Merck Sharp & Dohme LLC | $23.33 | 2022 | |
| Siemens Medical Solutions USA, INC. | $22.73 | 2023 | Artis Q Ceiling |
| Teleflex LLC | $17.96 | 2025 | Turnpike |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sostanie Enoru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.